Trademark: 97052052
Word
AHREXVY
Status
Dead
Status Code
606
Status Date
Monday, May 8, 2023
Serial Number
97052052
Mark Type
4000
Filing Date
Wednesday, September 29, 2021
Published for Opposition
Tuesday, August 9, 2022
Abandoned Date
Monday, May 8, 2023

Trademark Owner History
GlaxoSmithKline Biologicals SA - Owner At Publication

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
May 8, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 8, 2023
Abandonment - No Use Statement Filed
Oct 4, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 9, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2022
Published For Opposition
Aug 2, 2022
Teas Change Of Correspondence Received
Aug 2, 2022
Teas Change Of Domestic Representatives Address
Aug 2, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 2, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 20, 2022
Notification Of Notice Of Publication E-Mailed
Jul 6, 2022
Approved For Pub - Principal Register
Jun 29, 2022
Assigned To Examiner
Oct 27, 2021
New Application Office Supplied Data Entered
Oct 2, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24